EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial

MLA

Epi Kanker Team C, et al. EGFR-Targeted Fluorescence Molecular Imaging for Intraoperative Margin Assessment in Oral Cancer Patients: A Phase II Trial. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432123965&authtype=sso&custid=ns315887.

APA

Epi Kanker Team C, Cancer, JC onderzoeksprogramma Kanker, de Wit, J. G., Vonk, J., Voskuil, F. J., de Visscher, S. A. H. J., Schepman, K.-P., Hooghiemstra, W. T. R., Linssen, M. D., Elias, S. G., Halmos, G. B., Plaat, B. E. C., Doff, J. J., Rosenthal, E. L., Robinson, D., van der Vegt, B., Nagengast, W. B., van Dam, G. M., & Witjes, M. J. H. (2023). EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial.

Chicago

Epi Kanker Team C, Cancer, JC onderzoeksprogramma Kanker, Jaron G de Wit, Jasper Vonk, Floris J Voskuil, Sebastiaan A H J de Visscher, et al. 2023. “EGFR-Targeted Fluorescence Molecular Imaging for Intraoperative Margin Assessment in Oral Cancer Patients: A Phase II Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432123965&authtype=sso&custid=ns315887.